We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Will a Change of Diet Prevent Cancer?

By LabMedica International staff writers
Posted on 30 Jun 2011
Cancer researchers have found that a diet low in carbohydrates and high in protein reduced the risk of developing some types of cancer in a mouse model.

Investigators at the University of British Columbia (Vancouver, Canada) postulated that fast growing cancer cells should require significantly more glucose to grow and thrive than normal cells. More...
Furthermore, they reasoned that restricting glucose intake might slow or prevent tumor growth.

To examine this concept they implanted human tumor cells into various strains of mice, some of which were also growing mouse tumors. The mice were separated into two groups. One group was fed a typical Western diet, containing about 55% carbohydrate, 23% protein, and 22% fat. The second group received a highly modified diet (low CHO diet) that contained 15% carbohydrate, 58% protein, and 26% fat.

Results published in the June 14, 2011, online edition of the journal Cancer Research revealed that both mouse and human tumors grew more slowly in the mice that received the low CHO diet. While there was no significant weight difference between the tumor-bearing mice on the low CHO or Western diets, the low CHO-fed mice exhibited lower blood glucose, insulin, and lactate.

Combining a low CHO diet with chemotherapy increased the effect of the mTOR inhibitor CCI-779 and especially that of the potent anti-inflammatory COX-2 inhibitor Celebrex. In a genetically engineered mouse model of HER-2/neu–induced mammary cancer, tumor penetrance in mice on a Western diet was nearly 50% by the age of one year whereas no tumors were detected in mice on the low CHO diet.

Only one mouse on the Western diet achieved a normal life span, due to cancer-associated deaths, while more than 50% of the mice on the low CHO diet reached or exceeded the normal life span. "This shows that something as simple as a change in diet can have an impact on cancer risk," said senior author Dr. Gerald Krystal, professor of pathology and laboratory medicine at the University of British Columbia.

Related Links:

University of British Columbia




New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.